Showing results (931-940 of 960) with videos related to

Sort By:
Pageof 96
Gastroenterology|October 22, 2008
Pivotal role of mTOR signaling in hepatocellular carcinomaAugusto Villanueva, Derek Y Chiang, Pippa Newell, et al.
Cell Reports|July 21, 2025
PPM1M, an LRRK2-counteracting, phosphoRab12-preferring phosphatase with a potential link to Parkinson's diseaseClaire Y Chiang, Neringa Pratuseviciute, Yu-En Lin, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2022
Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant RecipientsAndrew H Karaba, Jake D Kim, Teresa P-Y Chiang, et al.
Circulation Research|June 7, 2021
Targeting the Microtubule EB1-CLASP2 Complex Modulates Na<sub>V</sub>1.5 at Intercalated DiscsGerard A Marchal, Mariam Jouni, David Y Chiang, et al.
Transplantation|July 21, 2022
Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External ValidationJennifer L Alejo, Jonathan Mitchell, Teresa P-Y Chiang, et al.
Molecular Cancer Research : MCR|August 31, 2017
Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based SubtypesLi Zhang, Kenzie D MacIsaac, Ting Zhou, et al.
The Journal of Experimental Medicine|February 19, 2025
Native stem cell transcriptional circuits define cardinal features of high-risk leukemiaQing Wang, Francesco Boccalatte, Jason Xu, et al.
The New England Journal of Medicine|October 17, 2008
Gene expression in fixed tissues and outcome in hepatocellular carcinomaYujin Hoshida, Augusto Villanueva, Masahiro Kobayashi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 11, 2023
Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipientsAndrew H Karaba, Jake D Kim, Teresa P-Y Chiang, et al.
Oncogene|July 25, 2012
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomasP Wang, Q Dong, C Zhang, et al.
Pageof 96